Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Mucositis × Rituximab × Clear all

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1 Other 1

Conditions

Lymphoma, Large B-Cell, Diffuse 369 Lymphoma 362 Lymphoma, Non-Hodgkin 305 Leukemia, Lymphocytic, Chronic, B-Cell 281 Lymphoma, Follicular 271 Lymphoma, Mantle-Cell 201 Lymphoma, B-Cell, Marginal Zone 145 Leukemia 114 Burkitt Lymphoma 102 Lymphoma, B-Cell 97 Waldenstrom Macroglobulinemia 93 Precursor Cell Lymphoblastic Leukemia-Lymphoma 84 Recurrence 76 Hodgkin Disease 56 Lymphoma, Large-Cell, Immunoblastic 53 Neoplasms 35 Myelodysplastic Syndromes 25 Multiple Myeloma 24 Leukemia, Myeloid, Acute 24 Lymphoma, Large-Cell, Anaplastic 22 Dendritic Cell Sarcoma, Interdigitating 21 Hematologic Neoplasms 19 Leukemia, Hairy Cell 18 Leukemia, Prolymphocytic 15 Intraocular Lymphoma 15 Neoplasms, Plasma Cell 12 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 11 Lymphoma, T-Cell 11 Leukemia, B-Cell 11 Hematologic Diseases 11

Interventions

Radiotherapy 7 Cisplatin 6 Radiation 4 Injections 4 Fibroblast Growth Factor 7 4 angiotensin I (1-7) 3 Propolis 3 Morphine 3 Low-Level Light Therapy 3 Drug Therapy 3 aluminum hydroxide, magnesium hydroxide, drug combination 2 Xylitol 2 Water 2 Radiotherapy, Intensity-Modulated 2 RRx-001 2 Probiotics 2 Pentoxifylline 2 Mouthwashes 2 Methotrexate 2 Melphalan 2 Lidocaine 2 Leucovorin 2 Interleukin 1 Receptor Antagonist Protein 2 Honey 2 Gabapentin 2 Fluorouracil 2 Diphenhydramine 2 Cryotherapy 2 Amifostine 2 tempol 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01085617 2025-03-30

UKALL14

University College, London

OtherOther hematologic neoplasm

Leukemia, Mucositis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡